Pages • 2
Genzyme Indivudal Paper Krunal ThakkarDr. Kun LiuMGT 6890 6th October 2015Individual Strategic Analysis: Genzyme was highly attractive to Sanofi because of its success applying a centered focus on rare/inherited diseases and to address loss revenue from a “patent cliff’ Sanofi may be facing. With over $1.8 Billion in Sales, 12,000 employees, and distinguished accomplishments like “National.